Status:
COMPLETED
Bilateral, Masked Comparison of PEG-400 Based Artificial Tear and Systane for the Treatment of Dry Eye Signs, Symptoms and Visual Quality
Lead Sponsor:
Bp Consulting, Inc
Conditions:
Dry Eye
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
To evaluate and compare the effects of PEG-400 based artificial tear and Systane tears in mild-moderate dry eye patients. TBUT, Visual impact and subjective evaluations will be assessed in this month ...
Eligibility Criteria
Inclusion
- Patient reported dry eye symptoms (episodic, annoying, activity limiting), SES OD.
- Physician assessment of mild-moderate dry eye
- Patient willing to instill drops QID and complete entire length of protocol.
- TBUT \< 10 seconds
- BCVA of 20/30 or better
Exclusion
- Current topical cyclosporine use (Restasis)
- Current Systane use
- Refractive surgery within the last 6 months
- Oral or topical corticosteroid use
- Severe dry eye patients by physician assessment
- current active Blepharitis
- Oral Doxycyclines use
- Oral Antihistamine use
Key Trial Info
Start Date :
February 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2008
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT00622037
Start Date
February 1 2008
End Date
May 1 2008
Last Update
February 3 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Florida Microsurgical Eye Institute
Boynton Beach, Florida, United States, 33426